ClearPoint Neuro (CLPT) Shares Outstanding (2011 - 2026)

ClearPoint Neuro has disclosed Shares Outstanding (Entity) across 16 years of filings, most recently posting $30.5 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 7.32% year-over-year to $30.5 million; the TTM figure through Jun 2026 stood at $30.5 million (up 7.32% YoY), while the FY2025 annual figure was $29.4 million, up 6.34% from the prior year.
• Shares Outstanding (Entity) came in at $30.5 million for Q2 2026 at ClearPoint Neuro, up from $30.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $30.5 million in Q2 2026 to a low of $23.7 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $26.7 million, with a median of $27.5 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) gained 14.65% in 2022 and rose 0.3% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $24.6 million in 2022, then increased by 0.3% to $24.7 million in 2023, then climbed by 12.03% to $27.6 million in 2024, then grew by 6.34% to $29.4 million in 2025, then gained by 3.86% to $30.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $30.5 million in Q2 2026, $30.0 million in Q1 2026, and $29.4 million in Q4 2025.